lycorine has been researched along with bortezomib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Liang, L; Liu, F; Liu, J; Luo, Y; Peng, Y; Qiu, L; Roy, M; Xiao, X; Ye, M; Zhang, J; Zhang, S; Zhou, W | 1 |
2 other study(ies) available for lycorine and bortezomib
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma.
Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Autophagy; Bortezomib; Cell Survival; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Heterografts; HMGB1 Protein; Humans; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Phenanthridines; Treatment Outcome; Tumor Cells, Cultured | 2016 |